<?xml version="1.0" encoding="UTF-8"?>
<AssessmentQuestion xmlns="http://soap.sforce.com/2006/04/metadata">
    <assessmentQuestionVersion>
        <isActive>true</isActive>
        <name>EculizumabPNH_Initial_PatientQualityOfLife_Q3</name>
        <optionSourceResponseValue>false</optionSourceResponseValue>
        <questionText>For most patients, it is expected that they will see an improvement in functional status, fatigue and/or  transfusion independence or a significant reduction in transfusion requirements. They will also experience either stabilization or improvement in organ dysfunction related to PNH (pulmonary hypertension, kidney impairment and prevention of thrombosis). If there are any other quality of life improvements you expect, please describe them below.</questionText>
        <status>Active</status>
        <versionNumber>2</versionNumber>
    </assessmentQuestionVersion>
    <dataType>TextArea</dataType>
    <developerName>EculizumabPNH_Initial_PatientQualityOfLife_Q3</developerName>
    <name>EculizumabPNH_Initial_PatientQualityOfLife_Q3</name>
    <questionCategory>Demographic</questionCategory>
</AssessmentQuestion>
